4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 17, 2012

Primary Completion Date

May 7, 2013

Study Completion Date

May 7, 2013

Conditions
Anaemia
Interventions
DRUG

GSK1278863

Tablet

OTHER

Placebo

Tablet

Trial Locations (55)

15401

GSK Investigational Site, Uniontown

16507

GSK Investigational Site, Erie

17109

GSK Investigational Site, Demmin

18017

GSK Investigational Site, Bethlehem

22297

GSK Investigational Site, Hamburg

27103

GSK Investigational Site, Winston-Salem

28401

GSK Investigational Site, Wilmington

28801

GSK Investigational Site, Asheville

31275

GSK Investigational Site, Lehrte

31406

GSK Investigational Site, Savannah

32117

GSK Investigational Site, Daytona Beach

32132

GSK Investigational Site, Edgewater

32258

GSK Investigational Site, Jacksonville

33028

GSK Investigational Site, Pembroke Pines

33145

GSK Investigational Site, Miami

33150

GSK Investigational Site, Miami

33173

GSK Investigational Site, Miami

33308

GSK Investigational Site, Fort Lauderdale

33952

GSK Investigational Site, Port Charlotte

34471

GSK Investigational Site, Ocala

43210

GSK Investigational Site, Columbus

48236

GSK Investigational Site, Detroit

60031

GSK Investigational Site, Gurnee

60201

GSK Investigational Site, Evanston

63741

GSK Investigational Site, Aschaffenburg

69120

GSK Investigational Site, Heidelberg

73116

GSK Investigational Site, Oklahoma City

75110

GSK Investigational Site, Corsicana

75402

GSK Investigational Site, Greenville

76011

GSK Investigational Site, Arlington

76502

GSK Investigational Site, Temple

77054

GSK Investigational Site, Houston

77099

GSK Investigational Site, Houston

78229

GSK Investigational Site, San Antonio

78751

GSK Investigational Site, Austin

80230

GSK Investigational Site, Denver

90022

GSK Investigational Site, Los Angeles

90025

GSK Investigational Site, Los Angeles

90057

GSK Investigational Site, Los Angeles

91307

GSK Investigational Site, West Hills

91702

GSK Investigational Site, Azusa

91710

GSK Investigational Site, Chino

91773

GSK Investigational Site, San Dimas

92505

GSK Investigational Site, Riverside

92868

GSK Investigational Site, Orange

93309

GSK Investigational Site, Bakersfield

97210

GSK Investigational Site, Portland

98383

GSK Investigational Site, Silverdale

91606-1559

GSK Investigational Site, North Hollywood

Unknown

GSK Investigational Site, Yuba City

GSK Investigational Site, Charlotte

T2R 0X7

GSK Investigational Site, Calgary

L6T 0G1

GSK Investigational Site, Brampton

P3E 5J1

GSK Investigational Site, Greater Sudbury

N6A 5A5

GSK Investigational Site, London

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

PPD Development, LP

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY

NCT01587898 - 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis | Biotech Hunter | Biotech Hunter